Beryl Drugs Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹7.66Cr |
Net Profits | ₹0.31Cr |
Net Profit Margins | 4.05% |
Highlights
Revenue:
Beryl Drugs Ltd’s revenue fell -6.47% since last year same period to ₹7.66Cr in the Q3 2023-2024. On a quarterly growth basis, Beryl Drugs Ltd has generated -5.32% fall in its revenue since last 3-months.
Net Profits:
Beryl Drugs Ltd’s net profit jumped 121.43% since last year same period to ₹0.31Cr in the Q3 2023-2024. On a quarterly growth basis, Beryl Drugs Ltd has generated 14.81% jump in its net profits since last 3-months.
Net Profit Margins:
Beryl Drugs Ltd’s net profit margin jumped 136.75% since last year same period to 4.05% in the Q3 2023-2024. On a quarterly growth basis, Beryl Drugs Ltd has generated 21.26% jump in its net profit margins since last 3-months.
